Arcadia Biosciences (NASDAQ:RKDA) Earns Sell Rating from Analysts at StockNews.com

StockNews.com began coverage on shares of Arcadia Biosciences (NASDAQ:RKDA) in a research report sent to investors on Monday morning. The firm issued a sell rating on the basic materials company’s stock.

Arcadia Biosciences Stock Performance

NASDAQ:RKDA opened at $4.86 on Monday. The stock has a market capitalization of $6.61 million, a PE ratio of -1.14 and a beta of 0.88. Arcadia Biosciences has a fifty-two week low of $1.85 and a fifty-two week high of $10.31. The company has a fifty day moving average of $5.28 and a two-hundred day moving average of $3.86.

Arcadia Biosciences Company Profile

Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.